Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 42.405B	--
Feb 6, 2025	2025/Q3	-- / 40.900B	--
Aug 9, 2024	2025/Q1	38.403B / --	--
Feb 8, 2024	2024/Q3	41.062B / --	--
Aug 10, 2023	2024/Q1	37.996B / --	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 42.405B--

Feb 6, 20252025/Q3-- / 40.900B--

Aug 9, 20242025/Q138.403B / ----

Feb 8, 20242024/Q341.062B / ----

Aug 10, 20232024/Q137.996B / ----

Unlock Free Earnings Estimates

Open Account

Ahresty Earnings Reports

Ahresty: Confirmation letter

Nov 12, 2024 01:52 ET

Ahresty: Semi-Annual Report - Term 104 (2024/04/01 - 2025/03/31)

Nov 12, 2024 01:51 ET

Ahresty: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)

Nov 12, 2024 01:00 ET

Ahresty: Notice regarding the recording of non-operating expenses, extraordinary losses, corporate tax adjustments, etc., and revisions to consolidated earnings forecasts (midterm and full year)

Oct 29, 2024 02:00 ET

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.